Vera Therapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2019 | — | $-36.5M | $3.6M |
| Mar 2020 | — | $-38.9M | $6.2M |
| Jun 2020 | — | $-42.5M | $4.1M |
| Sep 2020 | — | $-46.9M | $1.5M |
| Dec 2020 | $0 | $-89.3M | $53.7M |
| Mar 2021 | — | $-93.3M | $49.5M |
| Jun 2021 | — | $92.2M | $91.6M |
| Sep 2021 | — | $85.5M | $86.2M |
| Dec 2021 | $4.9M | $69.6M | $79.7M |
| Mar 2022 | $4.9M | $134.4M | $111.5M |
| Jun 2022 | $5.0M | $121.5M | $50.4M |
| Sep 2022 | $5.0M | $105.7M | $30.5M |
| Dec 2022 | $24.8M | $76.9M | $43.5M |
| Mar 2023 | $24.9M | $157.7M | $137.4M |
| Jun 2023 | $25.0M | $140.5M | $33.9M |
| Sep 2023 | $25.0M | $123.7M | $27.4M |
| Dec 2023 | $49.9M | $101.7M | $45.7M |
| Mar 2024 | $50.1M | $353.5M | $69.1M |
| Jun 2024 | $50.3M | $327.9M | $25.1M |
| Sep 2024 | $50.5M | $289.1M | $27.3M |
| Dec 2024 | $50.7M | $577.2M | $92.6M |
| Mar 2025 | $50.9M | $535.0M | $55.1M |
| Jun 2025 | $74.5M | $468.3M | $49.1M |
| Sep 2025 | $74.6M | $398.9M | $57.8M |
| Dec 2025 | $74.8M | $604.5M | $354.7M |
| Mar 2026 | $75.0M | $499.7M | $114.4M |
| Jun 2026 | $75.2M | $407.8M | $48.9M |